- Home
- UHS vs ALGN Comparison
UHS vs ALGN Comparison
Compare UHS & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHS
- ALGN
- Stock Information
- Founded
- UHS 1978
- ALGN 1997
- Country
- UHS United States
- ALGN United States
- Employees
- UHS N/A
- ALGN N/A
- Industry
- UHS Hospital/Nursing Management
- ALGN Industrial Specialties
- Sector
- UHS Health Care
- ALGN Health Care
- Exchange
- UHS Nasdaq
- ALGN Nasdaq
- Market Cap
- UHS 10.9B
- ALGN 9.5B
- IPO Year
- UHS N/A
- ALGN N/A
- Fundamental
- Price
- UHS $209.08
- ALGN $130.27
- Analyst Decision
- UHS Hold
- ALGN Buy
- Analyst Count
- UHS 14
- ALGN 13
- Target Price
- UHS $216.77
- ALGN $216.25
- AVG Volume (30 Days)
- UHS 688.0K
- ALGN 1.2M
- Earning Date
- UHS 10-23-2025
- ALGN 10-29-2025
- Dividend Yield
- UHS 0.39%
- ALGN N/A
- EPS Growth
- UHS 39.27
- ALGN 0.42
- EPS
- UHS 18.95
- ALGN 5.92
- Revenue
- UHS $16,460,285,000.00
- ALGN $3,964,802,000.00
- Revenue This Year
- UHS $9.67
- ALGN $2.03
- Revenue Next Year
- UHS $4.93
- ALGN $3.31
- P/E Ratio
- UHS $10.92
- ALGN $22.04
- Revenue Growth
- UHS 9.61
- ALGN 0.56
- 52 Week Low
- UHS $152.33
- ALGN $122.00
- 52 Week High
- UHS $240.26
- ALGN $246.19
- Technical
- Relative Strength Index (RSI)
- UHS 76.29
- ALGN 45.03
- Support Level
- UHS $200.90
- ALGN $123.02
- Resistance Level
- UHS $205.74
- ALGN $134.98
- Average True Range (ATR)
- UHS 4.29
- ALGN 3.22
- MACD
- UHS 0.85
- ALGN 1.24
- Stochastic Oscillator
- UHS 85.43
- ALGN 64.79
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
About ALGN Align Technology Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.